Wedbush Initiates Coverage On Zura Bio with Outperform Rating, Announces Price Target of $15
Benzinga Newsdesk 9 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wedbush analyst Martin Fan initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating and announces Price Target of $15.
Wedbush analyst Martin Fan initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating and announces Price Target of $15.